We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Internal Medicine

Internal Medicine

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Every Hour Counts: Emergency Department Boarding Linked to Increased Clinical Deterioration and Mortality
Emergency Medicineclinical deteriorationED Boarding

Every Hour Counts: Emergency Department Boarding Linked to Increased Clinical Deterioration and Mortality

By MedXY|Mar 25, 2026

A large-scale retrospective study involving over 170,000 patients demonstrates that prolonged emergency department boarding significantly increases the odds of early clinical deterioration and 28-day mortality, emphasizing the urgent need f

Beyond Shared Identity: How Physician-Patient Racial Concordance Modulates Inpatient Advance Care Planning
Internal MedicineAdvance Care Planninghealth equity

Beyond Shared Identity: How Physician-Patient Racial Concordance Modulates Inpatient Advance Care Planning

By MedXY|Mar 28, 2026

A large-scale study of 390,000 hospitalizations reveals that while racial concordance modestly increases advance care planning (ACP) discussions, physician race and systemic quality initiatives play significant, nuanced roles in end-of-life

Redefining Gout Management: Cardiovascular Risk Reduction via Treat-to-Target Urate-Lowering Therapy
Cardiologycardiovascular riskgout

Redefining Gout Management: Cardiovascular Risk Reduction via Treat-to-Target Urate-Lowering Therapy

By MedXY|Mar 28, 2026

Achieving serum urate targets <6 mg/dL (or <5 mg/dL) through Treat-to-Target (T2T) protocols significantly reduces major adverse cardiovascular events in gout patients, particularly those at high baseline risk.

Reduced Intestinal Epithelial GPX4 Expression Predicts Postoperative Crohn’s Disease Recurrence and Offers a Novel Therapeutic Target
GastroenterologyCrohn’s diseasegastroenterology

Reduced Intestinal Epithelial GPX4 Expression Predicts Postoperative Crohn’s Disease Recurrence and Offers a Novel Therapeutic Target

By MedXY|Mar 22, 2026

A breakthrough study identifies epithelial Glutathione peroxidase 4 (GPX4) deficiency as a potent predictor of Crohn’s disease recurrence after surgery. The research links this biomarker to endoplasmic reticulum stress and highlights

Hormones and Aging, Not Just Diet: Unmasking the Sex-Specific Drivers of Plasma Ketone Levels
Diabetes & EndocrinologyendocrinologyKetone Bodies

Hormones and Aging, Not Just Diet: Unmasking the Sex-Specific Drivers of Plasma Ketone Levels

By MedXY|Mar 22, 2026

A large-scale analysis of the PREVEND cohort reveals that fasting β-hydroxybutyrate levels are primarily driven by sex-specific factors: oral contraceptives and menopause in women, and aging in men, challenging the dietary-centric view of k

Beyond Statins: The Evolution and Clinical Impact of PCSK9 Inhibition in Cardiovascular Risk Management
Cardiologycardiovascular diseaseLDL Cholesterol

Beyond Statins: The Evolution and Clinical Impact of PCSK9 Inhibition in Cardiovascular Risk Management

By MedXY|Mar 21, 2026

This article explores the transformation of lipid management through PCSK9 inhibitors. From genetic discovery to landmark cardiovascular outcomes trials, we examine how monoclonal antibodies, RNA interference, and gene editing are redefinin

Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines
CardiologyCardiologyESC Guidelines

Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines

By MedXY|Mar 21, 2026

This article explores the critical differences between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting how the JACC Consensus provides a more robust prognostic framework for managing this emerging he

Impact of Polygenic Risk Scores on the Clinical Presentation and Glycaemic Variability of GCK-MODY
Diabetes & EndocrinologyendocrinologyGCK-MODY

Impact of Polygenic Risk Scores on the Clinical Presentation and Glycaemic Variability of GCK-MODY

By MedXY|Mar 20, 2026

This article explores how polygenic background modifies GCK-MODY clinical phenotypes, influencing HbA1c levels and diagnostic thresholds. Findings highlight the distinct polygenic patterns in GCK-MODY compared to HNF1A-MODY, emphasizing the

Optimizing the ‘When’ of Exercise: Afternoon and Evening Activity as a Precision Medicine Tool for Diabetes Risk Reduction
Diabetes & EndocrinologyChronobiologymetabolic health

Optimizing the ‘When’ of Exercise: Afternoon and Evening Activity as a Precision Medicine Tool for Diabetes Risk Reduction

By MedXY|Mar 20, 2026

New evidence from the UK Biobank and NHANES suggests that the timing of moderate-to-vigorous physical activity (MVPA) significantly impacts type 2 diabetes risk. Clustering activity in the afternoon and evening provides superior metabolic p

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial
Cardiologyatrial fibrillationCardiac Glutamatergic System

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial

By MedXY|Mar 20, 2026

This phase 2 trial demonstrates that memantine, an NMDA receptor antagonist, significantly reduces premature atrial contractions (PACs) and nonsustained atrial tachycardia burden, suggesting the cardiac glutamatergic system as a novel thera

Accelerated 3-Year MD Graduates Match or Exceed Traditional Peers in Residency Performance: Evidence from ACGME Milestone 2.0
Internal MedicineACGME MilestonesMedical Education

Accelerated 3-Year MD Graduates Match or Exceed Traditional Peers in Residency Performance: Evidence from ACGME Milestone 2.0

By MedXY|Mar 19, 2026

A comprehensive retrospective cohort study finds **Implementing Study Findings** I’m now integrating the Brenner et al. (2026) data into the “Key Findings” section. I’m focusing on providing a clear presentation of t

Post-Pandemic Firearm Acquisition and Household Exposure: Insights from the 2024 National Firearms Survey
Internal MedicineepidemiologyFirearm Safety

Post-Pandemic Firearm Acquisition and Household Exposure: Insights from the 2024 National Firearms Survey

By MedXY|Mar 19, 2026

The 2024 National Firearms Survey reveals that 29.8 million US adults acquired firearms between 2021 and 2024. This trend introduced 11.2 million new owners, significantly increasing household exposure for millions of adults and children, r

Holding GLP-1/GIP Agonists Before Upper Endoscopy Reduces Residual Gastric Volume Risk: Insights from the OCULUS Randomized Trial
GastroenterologyGLP-1/胰高血糖素激动剂Perioperative Safety

Holding GLP-1/GIP Agonists Before Upper Endoscopy Reduces Residual Gastric Volume Risk: Insights from the OCULUS Randomized Trial

By MedXY|Mar 19, 2026

The OCULUS randomized trial demonstrates that continuing GLP-1/GIP agonists before upper endoscopy significantly increases the risk of clinically significant residual gastric volume compared to holding a single dose, providing crucial evide

Breaking the Fasting Mandate: Is It Time to Re-evaluate Levothyroxine Administration?
Diabetes & EndocrinologyendocrinologyHypothyroidism

Breaking the Fasting Mandate: Is It Time to Re-evaluate Levothyroxine Administration?

By MedXY|Mar 17, 2026

A randomized clinical trial demonstrates that a 15% dose increase allows levothyroxine to be taken with breakfast without compromising TSH stability, significantly improving patient preference and well-being.

The Rising Tide of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Synthesis of Medication Eligibility and Clinical Implementation
CardiologyGLP-1RAHội Chứng CKM

The Rising Tide of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Synthesis of Medication Eligibility and Clinical Implementation

By MedXY|Mar 18, 2026

This review synthesizes population-level data on the eligibility for GLP-1RAs, SGLT2is, and nsMRAs, highlighting that over 60% of US adults meet indications for these transformative therapies.

Coronary Artery Calcium Scoring Remains the Definitive Risk Stratifier for Patients With Elevated Lipoprotein(a)
CardiologyCardiologycoronary artery calcium

Coronary Artery Calcium Scoring Remains the Definitive Risk Stratifier for Patients With Elevated Lipoprotein(a)

By MedXY|Mar 17, 2026

A large multicohort study involving 11,319 participants confirms that Coronary Artery Calcium (CAC) scoring effectively stratifies cardiovascular risk even in individuals with high Lipoprotein(a), providing clinical clarity for personalized

CRLF1 Secreted by Cardiac Fibroblasts: A New Driver and Potential Therapeutic Target for Hypertrophic Cardiomyopathy
CardiologyCardiac FibroblastsCRLF1

CRLF1 Secreted by Cardiac Fibroblasts: A New Driver and Potential Therapeutic Target for Hypertrophic Cardiomyopathy

By MedXY|Mar 17, 2026

This article explores a groundbreaking study identifying CRLF1, a protein secreted by cardiac fibroblasts, as a key driver of Hypertrophic Cardiomyopathy (HCM). This paracrine signaling mechanism offers a potential universal therapeutic tar

Strengthening the Patient Voice: New Guidance for Qualitative Research in Internal Medicine
Internal MedicineHealth ServicesNội khoa

Strengthening the Patient Voice: New Guidance for Qualitative Research in Internal Medicine

By MedXY|Mar 17, 2026

This article outlines new expert consensus on conducting rigorous qualitative research in internal medicine, providing a roadmap for investigators to move beyond numbers and capture the human experience of healthcare through methods like in

Prophylactic Haemostatic Strategies in Endobronchial Biopsy: Insights from the PROTECT Trial and Modern Bronchoscopic Practice
Clinical UpdatesbronchoscopyHaemostasis

Prophylactic Haemostatic Strategies in Endobronchial Biopsy: Insights from the PROTECT Trial and Modern Bronchoscopic Practice

By MedXY|Mar 18, 2026

This review evaluates the evidence for prophylactic haemostasis during endobronchial biopsy, centered on the PROTECT trial results, while integrating contemporary data on procedural safety, pre-procedural screening, and technical optimizati

Metformin and Ursodeoxycholic Acid Fail to Improve Post-COVID Recovery: Insights from a Randomized Controlled Trial
Infectious Diseaseslong COVIDmetformin

Metformin and Ursodeoxycholic Acid Fail to Improve Post-COVID Recovery: Insights from a Randomized Controlled Trial

By MedXY|Mar 13, 2026

A randomized clinical trial indicates that neither metformin nor ursodeoxycholic acid (UDCA) significantly improves recovery from postacute sequelae of SARS-CoV-2 (PASC) compared to placebo, highlighting the ongoing challenge of finding eff

Prev
8 / 22
1…678910…22
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles